|Bid||16.12 x 300|
|Ask||16.15 x 100|
|Day's Range||16.45 - 17.02|
|52 Week Range||16.45 - 52.66|
|PE Ratio (TTM)||211.41|
|Dividend & Yield||1.10 (6.50%)|
|1y Target Est||N/A|
It's not just Biogen, Teva, and other drugmakers. It's the entire system.
Teva Pharmaceutical is a generic manufacturer with a particular problem: It can’t find a leader or a strategy—at least not in Israel.
Teva Pharmaceutical Industries Ltd.’s women’s health unit is drawing interest from Church & Dwight Co. and Cooper Cos., people familiar with the matter said, as the troubled Israeli drugmaker sells assets ...